AI-generated summary
The authors randomized 251 adults with localized refractory non-segmental vitiligo to a 308 nm excimer laser plus oral JAK inhibitor, JAK inhibitor alone, excimer laser alone, or a positive control group over 52 weeks. They report that the combination produced a 14.20% higher repigmentation rate than the positive control group, with stable pigmentation and no recurrence at one year.
- Participants
- 251
- Who or what was studied
- Adults with localized refractory non-segmental vitiligo
- Wavelengths
- 308 nm
- Limits stated in the abstract
- The abstract does not describe the control group's treatment in detail or report the study's blinding, so the strength of the evidence cannot be fully assessed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 308 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Randomized controlled trial, Control group. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.